Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,601 signal articles · 135 in last 24h · 155,365 total before filter · latest 2h ago
135last 24h
852last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro192Earnings102M&A125Regulatory20Product22Analyst19
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Far Could RGTI Stock Drop If the Broader Market Breaks?
Trefis10d agobearish
How Far Could RGTI Stock Drop If the Broader Market Breaks?

Rigetti Computing (RGTI) trades near $15, about 73% below the high it set inside the past year. No market shock did that: the S&P 500 returned 17% over the past twelve months while Rigetti lost 8.5%. The 73% is measured from a high set inside those same twelve months, so the stock ran up hard before it fell. A fall like that in a rising market says the price is a bet on a road map.

The Stock Market Could Be in for an Autumn Fall. Why Wall Street is Getting Nervous.
Barrons.com10d agobearish
The Stock Market Could Be in for an Autumn Fall. Why Wall Street is Getting Nervous.

Wall Street is starting to turn cautious on stocks heading into the final months of the year, with a key investor survey and a new S&P 500 price target suggesting stocks are in for a rough autumn patch due to surging bond yields and soaring energy prices. The new set of outlooks, while not signaling an outright bearish take on stocks as they head toward the four-year anniversary of the current bull market in mid-October, nonetheless highlight a host of issues that have already have stalled performance over the past three months—and raise noticeable red flags for the near-term. Similarly, Lori Calvasina, head of U.S. equity strategy at RBC, argued earlier this week that “risks of a garden-variety pullback of 5% to 10% have grown” ahead of the midterm elections.

Jim Cramer Questions TJX After Marmaxx Stumbles
Insider Monkey10d agobearish
Jim Cramer Questions TJX After Marmaxx Stumbles

Jim Cramer raised concerns about The TJX Companies, Inc. (NYSE:TJX) during the September 10 episode of Mad Money, as he said: We had our CNBC Investing Club meeting today… I review each of the Charitable Trust positions on the call. This time, it was pretty clinical until I got to TJX, the off-price retailer. Candidly, […]

Bank of America Warns of 10%+ Drop in Q3 Investment Banking Fees
Insider Monkey10d agobearish
Bank of America Warns of 10%+ Drop in Q3 Investment Banking Fees

Bank of America Corporation (NYSE:BAC) expects third-quarter investment banking fees to fall by at least 10% year over year, which highlights a broader normalization across capital markets after an unusually strong first half of 2026. BofA expects investment banking fees of roughly $1.6 billion to $1.8 billion in the third quarter, compared with $2 billion […]

Dow Falls 500 Points After 10-Year Yield Tops 5%
Barrons.com10d agobearish
Dow Falls 500 Points After 10-Year Yield Tops 5%

The stock market picked a direction: down. The Dow Jones Industrial Average fell 500 points, or 1%, after oil prices and bond yields spiked. The S&P 500 fell 0.5%. The Nasdaq Composite dropped 0.6%. The move followed a jump in WTI crude oil futures, which rose 1.

AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss
Insider Monkey10d agobearish
AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss

AstraZeneca PLC (NYSE:AZN)’s breast cancer pill Etcamah (camizestrant) failed to meet the primary endpoint in the Phase III SERENA-4 trial, dealing a setback to one of the company’s key oncology growth opportunities. The trial evaluated Etcamah plus Pfizer’s Ibrance (palbociclib) in previously untreated patients with ER-positive, HER2-negative advanced breast cancer and found a numerical improvement […]